Healthcare -
Biotechnology - NASDAQ - US
$ 1.8349
-1.75 %
$ 17 M
Market Cap
-0.5
P/E
SABS - OPERATING INCOME
Operating Income SABS - SAB Biotherapeutics, Inc.
-42.9 M
LAST VALUE
-21.81%
2 YEAR CAGR
-37.68%
5 YEAR CAGR
0.00%
10 YEAR CAGR